(VIV) Vivendi - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000127771
Stock: Games, Music, Media, Publishing, Connectivity
Total Rating 22
Risk 78
Buy Signal -1.50
| Risk 5d forecast | |
|---|---|
| Volatility | 35.0% |
| Relative Tail Risk | -13.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.43 |
| Alpha | -55.24 |
| Character TTM | |
|---|---|
| Beta | 1.103 |
| Beta Downside | 2.428 |
| Drawdowns 3y | |
|---|---|
| Max DD | 73.47% |
| CAGR/Max DD | -0.42 |
EPS (Earnings per Share)
Revenue
Description: VIV Vivendi March 05, 2026
Vivendi SE is a French content, media, and entertainment conglomerate with global operations. The companys business model spans multiple sectors, including video games, recorded music, and audiovisual content production.
Vivendi creates and publishes games across mobile, PC, and console platforms, a common strategy in the diversified video game industry. Their music operations encompass recorded music, publishing, and merchandise, reflecting typical revenue streams for major music companies.
The company also provides online sports betting and telecommunications services, including fixed and mobile connectivity. This diversification into connectivity and betting is a strategy employed by some media groups to capture additional consumer spending. Vivendi further engages in publishing, travel retail, and television production.
For more detailed financial and operational insights, consider exploring ValueRay.
Headlines to watch out for
- Canal+ subscriber growth drives media revenue
- Havas advertising spend impacts profitability
- Gameloft game sales influence digital content revenue
- Universal Music Group streaming royalties boost earnings
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -6.05b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -3.04 > 1.0 |
| NWC/Revenue: -7.39% < 20% (prev -29.05%; Δ 21.66% < -1%) |
| CFO/TA 0.24 > 3% & CFO 1.78b > Net Income -6.05b |
| Net Debt (1.82b) to EBITDA (371.0m): 4.91 < 3 |
| Current Ratio: 0.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (996.1m) vs 12m ago -2.54% < -2% |
| Gross Margin: 48.32% > 18% (prev 0.47%; Δ 4.79k% > 0.5%) |
| Asset Turnover: 20.10% > 50% (prev 32.41%; Δ -12.31% > 0%) |
| Interest Coverage Ratio: -2.40 > 6 (EBITDA TTM 371.0m / Interest Expense TTM 211.0m) |
Altman Z'' 3.05
| A: -0.05 (Total Current Assets 363.0m - Total Current Liabilities 708.0m) / Total Assets 7.33b |
| B: 0.52 (Retained Earnings 3.79b / Total Assets 7.33b) |
| C: -0.02 (EBIT TTM -507.0m / Avg Total Assets 23.24b) |
| D: 1.74 (Book Value of Equity 4.36b / Total Liabilities 2.51b) |
| Altman-Z'' Score: 3.05 = A |
Beneish M -4.00
| DSRI: 0.04 (Receivables 97.0m/6.19b, Revenue 4.67b/12.69b) |
| GMI: 0.97 (GM 48.32% / 46.89%) |
| AQI: 1.49 (AQ_t 0.94 / AQ_t-1 0.63) |
| SGI: 0.37 (Revenue 4.67b / 12.69b) |
| TATA: -1.07 (NI -6.05b - CFO 1.78b) / TA 7.33b) |
| Beneish M-Score: -5.10 (Cap -4..+1) = AAA |
What is the price of VIV shares?
As of March 21, 2026, the stock is trading at EUR 1.71 with a total of 8,736,195 shares traded.
Over the past week, the price has changed by -12.64%, over one month by -22.43%, over three months by -26.96% and over the past year by -35.45%.
Over the past week, the price has changed by -12.64%, over one month by -22.43%, over three months by -26.96% and over the past year by -35.45%.
Is VIV a buy, sell or hold?
Vivendi has no consensus analysts rating.
What are the forecasts/targets for the VIV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.6 | 109.4% |
| Analysts Target Price | - | - |
VIV Fundamental Data Overview March 18, 2026
Market Cap USD = 3.56b (3.10b EUR * 1.1464 EUR.USD)
P/E Forward = 10.8696
P/S = 6.3283
P/B = 0.4052
P/EG = 1.6331
Revenue TTM = 4.67b EUR
EBIT TTM = -507.0m EUR
EBITDA TTM = 371.0m EUR
Long Term Debt = 1.50b EUR (from longTermDebt, last quarter)
Short Term Debt = 474.0m EUR (from shortTermDebt, last quarter)
Debt = 1.99b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b EUR (from netDebt column, last quarter)
Enterprise Value = 4.93b EUR (3.10b + Debt 1.99b - CCE 167.0m)
Interest Coverage Ratio = -2.40 (Ebit TTM -507.0m / Interest Expense TTM 211.0m)
EV/FCF = -74.66x (Enterprise Value 4.93b / FCF TTM -66.0m)
FCF Yield = -1.34% (FCF TTM -66.0m / Enterprise Value 4.93b)
FCF Margin = -1.41% (FCF TTM -66.0m / Revenue TTM 4.67b)
Net Margin = -129.6% (Net Income TTM -6.05b / Revenue TTM 4.67b)
Gross Margin = 48.32% ((Revenue TTM 4.67b - Cost of Revenue TTM 2.41b) / Revenue TTM)
Gross Margin QoQ = 30.34% (prev 30.34%)
Tobins Q-Ratio = 0.67 (Enterprise Value 4.93b / Total Assets 7.33b)
Interest Expense / Debt = 3.11% (Interest Expense 62.0m / Debt 1.99b)
Taxrate = 14.29% (2.50m / 17.5m)
NOPAT = -434.6m (EBIT -507.0m * (1 - 14.29%)) [loss with tax shield]
Current Ratio = 0.51 (Total Current Assets 363.0m / Total Current Liabilities 708.0m)
Debt / Equity = 0.41 (Debt 1.99b / totalStockholderEquity, last quarter 4.82b)
Debt / EBITDA = 4.91 (Net Debt 1.82b / EBITDA 371.0m)
Debt / FCF = -27.59 (negative FCF - burning cash) (Net Debt 1.82b / FCF TTM -66.0m)
Total Stockholder Equity = 4.70b (last 4 quarters mean from totalStockholderEquity)
RoA = -26.05% (Net Income -6.05b / Total Assets 7.33b)
RoE = -128.7% (Net Income TTM -6.05b / Total Stockholder Equity 4.70b)
RoCE = -8.18% (EBIT -507.0m / Capital Employed (Equity 4.70b + L.T.Debt 1.50b))
RoIC = -6.21% (negative operating profit) (NOPAT -434.6m / Invested Capital 7.00b)
WACC = 7.12% (E(3.10b)/V(5.09b) * Re(9.98%) + D(1.99b)/V(5.09b) * Rd(3.11%) * (1-Tc(0.14)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -4.97%
[DCF] Fair Price = unknown (Cash Flow -66.0m)
EPS Correlation: -14.06 | EPS CAGR: 141.5% | SUE: 0.0 | # QB: 0
Revenue Correlation: -52.69 | Revenue CAGR: -62.09% | SUE: -0.00 | # QB: 0
EPS next Year (2026-12-31): EPS=0.10 | Chg7d=+0.000 | Chg30d=-0.001 | Revisions Net=+0 | Growth EPS=+65.5% | Growth Revenue=+2.8%
P/E Forward = 10.8696
P/S = 6.3283
P/B = 0.4052
P/EG = 1.6331
Revenue TTM = 4.67b EUR
EBIT TTM = -507.0m EUR
EBITDA TTM = 371.0m EUR
Long Term Debt = 1.50b EUR (from longTermDebt, last quarter)
Short Term Debt = 474.0m EUR (from shortTermDebt, last quarter)
Debt = 1.99b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b EUR (from netDebt column, last quarter)
Enterprise Value = 4.93b EUR (3.10b + Debt 1.99b - CCE 167.0m)
Interest Coverage Ratio = -2.40 (Ebit TTM -507.0m / Interest Expense TTM 211.0m)
EV/FCF = -74.66x (Enterprise Value 4.93b / FCF TTM -66.0m)
FCF Yield = -1.34% (FCF TTM -66.0m / Enterprise Value 4.93b)
FCF Margin = -1.41% (FCF TTM -66.0m / Revenue TTM 4.67b)
Net Margin = -129.6% (Net Income TTM -6.05b / Revenue TTM 4.67b)
Gross Margin = 48.32% ((Revenue TTM 4.67b - Cost of Revenue TTM 2.41b) / Revenue TTM)
Gross Margin QoQ = 30.34% (prev 30.34%)
Tobins Q-Ratio = 0.67 (Enterprise Value 4.93b / Total Assets 7.33b)
Interest Expense / Debt = 3.11% (Interest Expense 62.0m / Debt 1.99b)
Taxrate = 14.29% (2.50m / 17.5m)
NOPAT = -434.6m (EBIT -507.0m * (1 - 14.29%)) [loss with tax shield]
Current Ratio = 0.51 (Total Current Assets 363.0m / Total Current Liabilities 708.0m)
Debt / Equity = 0.41 (Debt 1.99b / totalStockholderEquity, last quarter 4.82b)
Debt / EBITDA = 4.91 (Net Debt 1.82b / EBITDA 371.0m)
Debt / FCF = -27.59 (negative FCF - burning cash) (Net Debt 1.82b / FCF TTM -66.0m)
Total Stockholder Equity = 4.70b (last 4 quarters mean from totalStockholderEquity)
RoA = -26.05% (Net Income -6.05b / Total Assets 7.33b)
RoE = -128.7% (Net Income TTM -6.05b / Total Stockholder Equity 4.70b)
RoCE = -8.18% (EBIT -507.0m / Capital Employed (Equity 4.70b + L.T.Debt 1.50b))
RoIC = -6.21% (negative operating profit) (NOPAT -434.6m / Invested Capital 7.00b)
WACC = 7.12% (E(3.10b)/V(5.09b) * Re(9.98%) + D(1.99b)/V(5.09b) * Rd(3.11%) * (1-Tc(0.14)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -4.97%
[DCF] Fair Price = unknown (Cash Flow -66.0m)
EPS Correlation: -14.06 | EPS CAGR: 141.5% | SUE: 0.0 | # QB: 0
Revenue Correlation: -52.69 | Revenue CAGR: -62.09% | SUE: -0.00 | # QB: 0
EPS next Year (2026-12-31): EPS=0.10 | Chg7d=+0.000 | Chg30d=-0.001 | Revisions Net=+0 | Growth EPS=+65.5% | Growth Revenue=+2.8%